Low Dose Atropine Eye Drops Under Review for Pediatric Myopi

The FDA has accepted for review the NDA for NVK002 (low dose atropine 0.01%) for the treatment of children with myopia.

Related Keywords

, Drug Administration , New Drug Application , Spherical Equivalent Refraction , Navneet Puri Phd ,